BioCentury
ARTICLE | Finance

Bubble floats on

Japan biotechs unaffected by miss on AnGes, Vical melanoma vaccine

August 19, 2013 7:00 AM UTC

Japan's biotech investors punished only AnGes MG Inc. (Tokyo:4563) last week after partner Vical Inc. (NASDAQ:VICL) said it is discontinuing cancer immunotherapy Allovectin velimogene aliplasmid.

AnGes fell ¥75,900, closing the week down 59% to ¥52,600...